Welcome to our dedicated page for CELESTICA SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
Celestica Inc. reported an equity compensation transaction by one of its directors on a Form 4. On 12/31/2025, the director acquired 127 director share units, listed as derivative securities with a price of $0, reflecting a grant rather than an open-market purchase.
After this transaction, the director beneficially owns 531 director share units, held directly. According to the disclosure, each director share unit represents a contingent right to receive one common share of Celestica or an equivalent value in cash, at the company’s discretion, when the holder stops serving as a director, consultant or other service provider. This filing highlights ongoing alignment of director compensation with shareholder interests through share-based awards.
Celestica Inc. director reports grant of restricted share units
A director of Celestica Inc. (CLS) filed a Form 4 disclosing an equity award dated December 31, 2025. The reporting person received 129 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the holder's election.
According to the disclosure, one-third of the 129 RSUs vests annually over three years on the anniversary of the grant date. This filing reflects routine equity-based compensation for a board member rather than an open‑market purchase or sale of Celestica shares.
Celestica Inc. director reports receipt of equity-based compensation. A company director filed a Form 4 showing the acquisition of 118 director share units on 12/31/2025. These units are derivative securities that each represent a contingent right to receive one common share or an equivalent cash value, at Celestica’s discretion, when the holder stops serving as a director, consultant or other service provider.
Following this transaction, the director beneficially owns 495 director share units in total, held directly. The transaction was coded as an acquisition at a stated price of $0, indicating it is part of the director’s compensation rather than an open-market purchase.
Celestica Inc. director reports equity award activity and share withholding. A director of Celestica Inc. (CLS) reported several transactions dated 12/31/2025. The filing shows 4,266 common shares acquired at a stated price of $0 and 2,049 common shares disposed of at $299.45 to satisfy tax withholding on vested restricted share units (RSUs), leaving 18,547 common shares held directly.
Derivative tables show RSUs being exercised into common shares and director share units being credited. RSU grants made on December 31 of 2022, 2023, and 2024 each vest in three equal annual installments, and each RSU represents a contingent right to receive one common share or cash at the holder’s election. Director share units each represent a contingent right to receive one common share or cash when the holder ceases serving the company.
Celestica Inc. announced that Dr. Luis Müller plans to resign from its Board of Directors, including his roles as Chair of the Audit Committee and member of other board committees, effective at the conclusion of the regularly scheduled meeting on January 28, 2026. The company states that his decision is for personal reasons related to other professional commitments and not due to any disagreement with Celestica regarding its operations, policies, or practices.
To ensure continuity in oversight, the Board has appointed current director Amar Maletira to become Chair of the Audit Committee effective upon Dr. Müller’s resignation. Maletira brings over 25 years of public company business, strategic, and finance leadership experience, including multiple Chief Financial Officer roles, and has been determined by the Board to possess the financial expertise appropriate for this key governance position.
Celestica Inc. (CLS) Chief Legal Officer filed an amended Form 4 to report an equity award. On February 4, 2025, the reporting person received 2,317 restricted share units (RSUs), each representing a right to one common share or cash of equal value at the holder's election. These RSUs vest in two equal installments on February 4, 2026 and February 4, 2027. The amendment corrects the earliest transaction date and adds this previously omitted RSU grant, while all other information from the original filing remains unchanged.
Celestica Inc. Chief Financial Officer insider activity shows routine equity compensation events reported on a Form 4. On 12/01/2025, the CFO acquired 20,408 common shares through the vesting and settlement of previously granted restricted share units at an exercise price of $0. On the same date, 10,925 common shares were disposed of at $344.41 per share to cover tax withholding obligations arising from the RSU vesting, leaving the reporting person with 9,483 common shares held directly.
The derivative table shows 20,408 restricted share units exercised into common shares, reducing the reporting person’s RSU balance to zero for that grant. The filing notes that each RSU represents a contingent right to receive one common share or an equivalent cash amount, and that the original grant of 61,224 RSUs from 01/31/2023 vests in three installments over a three-year period.
Celestica Inc.'s Chief Human Resources Officer reported several equity transactions in company common shares on 12/01/2025. The officer acquired 6,802 common shares at an exercise price of $0 through the vesting and settlement of restricted share units (RSUs), increasing directly held shares before subsequent transactions.
To cover tax withholding arising from the RSU vesting, 3,642 shares were withheld and disposed of at $323.38 per share, and an additional 3,160 shares were sold at the same price. After these transactions, the officer directly owned 13,892 common shares and held no remaining RSUs from this grant.
Celestica Inc. reported an insider equity transaction by its President. On 12/01/2025, the officer acquired 17,792 common shares through the vesting and settlement of restricted share units at an exercise price of $0, increasing directly held shares. On the same date, 8,248 common shares were disposed of at $344.41 per share to cover tax withholding obligations tied to the RSU vesting. Following these transactions, the officer directly owned 108,970 common shares. The underlying RSU award covered 17,792 common shares and was fully settled, leaving no derivative securities from that grant outstanding.
Celestica Inc. Chief Operations Officer reports RSU vesting, tax withholding, and share sale. On 12/01/2025, 17,792 common shares were acquired at an exercise price of $0 upon the vesting and settlement of restricted share units (RSUs). On the same date, 8,605 of these shares were disposed of at $323.38 per share to cover tax withholding obligations, and 9,187 shares were sold in a market transaction at $323.38 per share, leaving 0 common shares held directly after these transactions.
These activities relate to an RSU grant of 53,375 units awarded on January 31, 2023, which vests ratably over three years, including on December 1 following the second anniversary of the grant date. Each RSU represents a contingent right to receive one common share or an equivalent cash amount at the holder’s election.